Anterior Segment Organ Culture Platform for Tracking Open Globe Injuries and Therapeutic Performance
August 25th, 2021
Open globe eye injuries may go untreated for multiple days in rural or military-relevant scenarios, resulting in blindness. Therapeutics are needed to minimize loss of vision. Here, we detail an organ culture open globe injury model. With this model, potential therapeutics for stabilizing these injuries can be properly evaluated.
Overview
This article presents an anterior segment organ culture model for assessing open globe injuries, which can lead to permanent vision loss if untreated. The model allows for the evaluation of potential therapeutics aimed at stabilizing these injuries without the need for animal testing.
Key Study Components
Area of Science
- Neuroscience
- Ophthalmology
- Injury Models
Background
- Open globe injuries can result in blindness if not treated promptly.
- Rural and military settings may delay treatment.
- Current therapeutic options are limited.
- Organ culture models can provide a viable alternative for testing therapeutics.
Purpose of Study
- To develop a model for studying open globe injuries.
- To evaluate potential therapeutics for stabilizing these injuries.
- To minimize the need for animal testing in research.
Methods Used
- Establishment of an organ culture platform.
- Tracking of open globe injuries over a period of three or more days.
- Evaluation of therapeutics aimed at injury stabilization.
- Demonstration of the procedure by a trained technician.
Main Results
- The organ culture model effectively mimics open globe injuries.
- Potential therapeutics can be assessed for efficacy.
- The model allows for extended observation of injury progression.
- Results indicate a promising approach to injury management.
Conclusions
- The organ culture model is a valuable tool for studying open globe injuries.
- It provides a platform for testing new therapeutics without animal use.
- Further research is needed to validate findings and explore additional treatments.
Frequently Asked Questions
Executive Industry Relevance
This anterior segment organ culture platform enables biopharma R&D teams to evaluate therapeutic candidates for open globe injury stabilization in a physiologically relevant, animal-free system. By maintaining porcine anterior segment tissue at physiological intraocular pressure and tracking pressure changes over 72 hours, the model provides quantitative readouts for assessing wound-sealing efficacy. This supports early de-risking of biomaterial therapeutics intended for use in resource-limited settings such as rural or military medicine where delayed treatment increases infection and tissue viability risks.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses related to intraocular pressure restoration and wound sealing mechanisms.
- Operational Value: Provides a reproducible platform for functional target validation without live animal models.
Screening & Assay Development
- Scientific Value: Supports preparation of validated biological systems for standardized assessment of corneal transparency, ocular mechanics, and epithelial integrity.
- Operational Value: Facilitates assay standardization through controlled injury induction and longitudinal pressure monitoring.
Translational & Preclinical Research
- Scientific Value: Offers disease-relevant system continuity from discovery through preclinical validation by mimicking human-relevant injury sizes up to 4.5 mm.
- Operational Value: Enables risk-adjusted advancement decisions by tracking therapeutic performance over multiple days post-injury.
Pipeline & Workflow Integration
The method integrates into early discovery workflows by providing quantitative intraocular pressure measurements that inform lead identification and preclinical progression decisions for ocular wound-sealing therapeutics.
- Discovery Biology: Supports hypothesis testing of biomaterial efficacy in restoring physiological pressure after open globe injury.
- Screening: Delivers assay readiness via standardized pneumatic puncture injury generation and real-time pressure tracking.
- Analytics: Generates quantitative dependent variable measurements (intraocular pressure) enabling comparison of therapeutic interventions across conditions.
- Translational Research: Connects to preclinical continuity through functional readouts like corneal epithelium health and tissue viability assessment.
- Enterprise Reuse: Establishes a reusable capability for iterative therapeutic screening across multiple candidate biomaterials.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by reducing mechanistic ambiguity in wound-sealing mechanism evaluation.
- Operational Value: Enhances reproducibility through standardized organ culture maintenance and injury induction protocols.
- Strategic Value: Improves go/no-go decisions by providing early efficacy signals before costly in vivo studies.
- Portfolio Impact: Enables risk-adjusted prioritization of ocular therapeutics based on pressure restoration and tissue viability outcomes.
Implementation Considerations
- Requires expertise in microsurgical tissue dissection and anterior segment isolation.
- Depends on pneumatic puncture platform and pressure transducer instrumentation for injury induction and monitoring.
- Necessitates cross-team standardization of media handling, bubble removal, and dish assembly procedures.
- Involves adaptation considerations when extending beyond porcine tissue to other species or disease models.
- Includes practical limitations such as tissue compliance risks from over-tightening the clamping ring during setup.
Biopharma FAQs
Chapters in this video
0:04
Introduction
0:38
Dissection Setup
1:07
Tissue Dissection
2:15
Anterior Segments Setup in Organ Culture Dishes
3:58
Starting Anterior Segment Organ Culture
4:30
Open Globe Injury Induction
5:29
Results: Corneal Integrity and Intraocular Pressure Assessment after Open Globe Injury
6:53
Conclusion
